Man Group plc

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1637460 LONDON, X0

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$177,151

-$181,266 QoQ

Shares Held

155,396

-39.7% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#55

of 170 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. AKBA ranks #30 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,805,003	$129,707,515
2	NBIX	Neurocrine Biosciences Inc	601,019	$101,295,742
3	UTHR	UNITED THERAPEUTICS Corp	134,890	$73,087,447
4	VTRS	Viatris Inc	3,523,052	$55,946,065
5	PRGO	PERRIGO Co plc	1,530,206	$15,898,840
6	BCRX	Biocryst Pharmaceuticals Inc	732,867	$7,328,670
7	SUPN	Supernus Pharmaceuticals, Inc.	156,422	$7,275,186
8	BHC	Bausch Health Companies Inc.	1,451,781	$7,157,279

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$177,151	155,396	-39.7%	Shares	Defined	2026-08-14
2026-03-31	$358,417	257,854	+23.6%	Shares	Defined	2026-05-15
2025-12-31	$335,837	208,595	+67.6%	Shares	Defined	2026-02-17
2025-09-30	$339,682	124,426	+198.3%	Shares	Defined	2025-11-14
2025-06-30	$151,828	41,711	-4.9%	Shares	Defined	2025-08-14
2022-09-30	$13,863	43,873	+84.7%	Shares	Sole	2022-11-14
2022-06-30	$11,000	30,502	—	Principal	Defined	2022-08-15
2021-03-31	$80,424	23,759	-83.4%	Shares	Defined	2021-05-17
2020-12-31	$399,856	142,806	-3.2%	Shares	Defined	2021-02-16
2020-09-30	$370,320	147,538	-12.1%	Shares	Defined	2020-11-16
2020-06-30	$2,278,899	167,813	-23.4%	Shares	Defined	2020-08-14
2020-03-31	$1,660,823	219,106	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.